In the health damage compensation system following the administration of the COVID-19 vaccine, the review process is experiencing delays, bringing to light the reality of individuals seeking relief who continue to wait. Among the nearly 10,000 applications accepted by the government, over 30% are still awaiting the commencement of the review process, leading to a situation where applicants must endure a wait of one and a half years or more for disbursement.

As a specific case, a 53-year-old woman in Nasushiobara City, Tochigi Prefecture, expressed the difficulty of coping with the lack of resolution in the case of her father, who developed Guillain-Barré syndrome and passed away after receiving the COVID-19 vaccine. The review committee of the system is struggling to cope with the overwhelming surge in applications related to COVID-19 vaccinations, with over 30% of cases remaining unaddressed, highlighting concerns about the system's unforeseen challenges.

新型コロナウイルスワクチン接種後の健康被害救済制度において、適用審査が滞り、救済を求める人々が待ち続けている実態が浮き彫りになっています。国が受理した１万件近い応募のうち、３割強がまだ審査開始前であり、申請者は1年半以上の間、支給を待たねばならない事態も発生しています。

具体的な事例として、栃木県那須塩原市の女性（５３）は、父親が新型コロナワクチン接種後にギラン・バレー症候群を発症し亡くなったが、半年以上経っても救済結果が出ておらず、感情の整理が難しいと訴えています。制度の審査会は、新型コロナ接種関連の応募が激増し、３割強の件数に対応できておらず、枠組みの「想定外」が問題視されています。